Boston Advisors Has Upped Pfizer Com (PFE) Stake; Last Week Manning and Napier (MN) Analysts

November 15, 2017 - By Henry Gaston

Boston Advisors Llc increased Pfizer Inc Com (PFE) stake by 42.21% reported in 2017Q2 SEC filing. Boston Advisors Llc acquired 131,913 shares as Pfizer Inc Com (PFE)’s stock declined 3.45%. The Boston Advisors Llc holds 444,413 shares with $14.93M value, up from 312,500 last quarter. Pfizer Inc Com now has $210.89 billion valuation. The stock declined 0.17% or $0.06 reaching $35.32 on the news. About 148,092 shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since November 15, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Among 7 analysts covering Manning & Napier Advisors (NYSE:MN), 0 have Buy rating, 3 Sell and 4 Hold. Therefore 0 are positive. Manning & Napier Advisors had 20 analyst reports since August 3, 2015 according to SRatingsIntel. On Monday, September 4 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. As per Friday, November 10, the company rating was maintained by Keefe Bruyette & Woods. The stock of Manning and Napier Inc (NYSE:MN) has “Neutral” rating given on Friday, July 15 by Credit Suisse. Keefe Bruyette & Woods maintained Manning and Napier Inc (NYSE:MN) rating on Friday, October 6. Keefe Bruyette & Woods has “Hold” rating and $4.0 target. The firm has “Market Perform” rating by Wood given on Friday, October 14. The firm has “Hold” rating given on Tuesday, August 1 by Keefe Bruyette & Woods. The firm has “Market Perform” rating given on Thursday, September 3 by Wood. The stock has “Mkt Perform” rating by Raymond James on Monday, September 14. The rating was upgraded by Keefe Bruyette & Woods on Wednesday, June 14 to “Mkt Perform”. The firm has “Neutral” rating given on Monday, January 11 by Credit Suisse. See Manning and Napier Inc (NYSE:MN) latest ratings:

10/11/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $4.0 Maintain
03/11/2017 Broker: Needham Rating: Hold Maintain
06/10/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $4.0 Maintain
04/09/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $4.0 Maintain
01/08/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $4.0000 Maintain
21/07/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $4.5000 Maintain
14/06/2017 Broker: Keefe Bruyette & Woods Old Rating: Underperform New Rating: Mkt Perform Upgrade

Boston Advisors Llc decreased Apple Inc Com (NASDAQ:AAPL) stake by 58,702 shares to 1.21M valued at $173.67 million in 2017Q2. It also reduced Timken Co Com (NYSE:TKR) stake by 8,900 shares and now owns 141,630 shares. Selective Ins Group Inc Com (NASDAQ:SIGI) was reduced too.

Investors sentiment decreased to 0.94 in 2017 Q2. Its down 0.01, from 0.95 in 2017Q1. It worsened, as 58 investors sold PFE shares while 716 reduced holdings. 112 funds opened positions while 612 raised stakes. 4.02 billion shares or 1.07% less from 4.06 billion shares in 2017Q1 were reported. Wendell David Assocs reported 46,691 shares. Moreover, Lsv Asset Mgmt has 1.99% invested in Pfizer Inc. (NYSE:PFE) for 33.28 million shares. Rothschild Investment Il accumulated 286,031 shares. Virtus Inv Advisers, a Connecticut-based fund reported 29,241 shares. Hgk Asset Mngmt holds 1.28% or 271,419 shares in its portfolio. Magnetar Limited Liability Corp holds 0.05% of its portfolio in Pfizer Inc. (NYSE:PFE) for 77,233 shares. Ontario – Canada-based Sentry Investments Corporation has invested 0.67% in Pfizer Inc. (NYSE:PFE). Lingohr Partner Asset Mgmt Gmbh holds 0.73% of its portfolio in Pfizer Inc. (NYSE:PFE) for 36,700 shares. Becker Cap Mngmt invested 1.79% in Pfizer Inc. (NYSE:PFE). British Columbia Invest Mgmt, British Columbia – Canada-based fund reported 2.59 million shares. Blackrock, a New York-based fund reported 441.40 million shares. Professional Advisory holds 26,795 shares or 0.2% of its portfolio. M&T Bank & Trust Corporation holds 0.79% or 3.98M shares. Kames Public Ltd Co stated it has 0% of its portfolio in Pfizer Inc. (NYSE:PFE). Patten And Patten Tn holds 0.61% of its portfolio in Pfizer Inc. (NYSE:PFE) for 165,475 shares.

Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $38.62’s average target is 9.34% above currents $35.32 stock price. Pfizer had 65 analyst reports since July 29, 2015 according to SRatingsIntel. On Thursday, April 7 the stock rating was reinitiated by JP Morgan with “Overweight”. The rating was upgraded by Cowen & Co to “Outperform” on Tuesday, October 20. SunTrust maintained the stock with “Hold” rating in Monday, October 16 report. The firm earned “Neutral” rating on Friday, December 2 by Guggenheim. BMO Capital Markets downgraded the shares of PFE in report on Wednesday, November 2 to “Market Perform” rating. The firm earned “Overweight” rating on Friday, August 28 by Piper Jaffray. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Monday, August 14 by Cowen & Co. On Thursday, July 20 the stock rating was downgraded by Credit Suisse to “Neutral”. The stock has “Hold” rating by Societe Generale on Wednesday, April 6. The stock of Pfizer Inc. (NYSE:PFE) has “Outperform” rating given on Monday, May 9 by Credit Suisse.

Investors sentiment decreased to 0.92 in 2017 Q2. Its down 0.27, from 1.19 in 2017Q1. It worsened, as 17 investors sold Manning and Napier Inc shares while 20 reduced holdings. 16 funds opened positions while 18 raised stakes. 8.54 million shares or 17.24% less from 10.32 million shares in 2017Q1 were reported. Axa reported 21,700 shares stake. Royal Fincl Bank Of Canada accumulated 69,200 shares. Gsa Capital Partners Ltd Liability Partnership holds 105,789 shares. Renaissance Technologies Limited Liability Corporation accumulated 0.01% or 1.27 million shares. Bnp Paribas Arbitrage Sa holds 0% of its portfolio in Manning and Napier Inc (NYSE:MN) for 22 shares. Morgan Stanley has 0% invested in Manning and Napier Inc (NYSE:MN). National Bank Of America De reported 5,722 shares. Federated Invsts Pa owns 3,529 shares for 0% of their portfolio. Envestnet Asset Management holds 6 shares or 0% of its portfolio. Los Angeles Capital Mgmt & Equity Rech holds 22,040 shares. Element Cap Management Ltd Liability Com has invested 0.06% in Manning and Napier Inc (NYSE:MN). Hancock invested in 0.01% or 36,742 shares. Citadel Advisors stated it has 0% in Manning and Napier Inc (NYSE:MN). Paloma Partners Com holds 53,900 shares or 0% of its portfolio. Spark Inv Mgmt Limited Co invested in 0.01% or 41,400 shares.

Manning & Napier, Inc. is an independent investment management company. The company has market cap of $56.40 million. The Firm operates through investment management industry segment. It has a 16.45 P/E ratio. It provides a range of investment solutions through separately managed accounts, mutual funds and collective investment trust funds, as well as a range of consultative services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com